VTAK

Catheter Precision, Inc. (VTAK)

Market Closed
12 Dec, 20:00
AMEX AMEX
$
2. 52
-0.18
-6.62%
$
2.6M Market Cap
- P/E Ratio
0% Div Yield
32,603 Volume
0 Eps
$ 2.7
Previous Close
Day Range
2.48 2.77
Year Range
1.49 15.77
Want to track VTAK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

VTAK closed yesterday lower at $2.52, a decrease of 6.62% from Thursday's close, completing a monthly increase of 22.57% or $0.46. Over the past 12 months, VTAK stock gained 448.91%.
VTAK is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, missed the consensus estimates by -1.7%. On average, the company has fell short of earnings expectations by -0.57%, based on the last three reports.
Catheter Precision, Inc. has completed 4 stock splits, with the recent split occurring on Aug 15, 2025.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on AMEX (USD).

VTAK Chart

Similar

Actinium Pharmaceuticals Inc.
$ 1.5
+3.79%
Maia Biotechnology Inc.
$ 1.36
-16.77%
IGC
IGC Pharma Inc.
$ 0.35
+6.1%
Nanoviricides Inc.
$ 1.25
-3.85%
Neuraxis Inc.
$ 2.65
+0.76%
Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC

Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC

FORT MILL, SC / ACCESSWIRE / January 15, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has entered into a definitive agreement to acquire PeriKard, LLC., in a transaction involving the issuance of restricted VTAK common stock for 100% of the LLC interests in PeriKard.

Accesswire | 11 months ago
Catheter Precision, Inc. Announces Initial LockeT Purchase From the University of Tennessee Medical Center

Catheter Precision, Inc. Announces Initial LockeT Purchase From the University of Tennessee Medical Center

FORT MILL, SC / ACCESSWIRE / January 13, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced it has received its first purchase order for LockeT from the southeast region. As previously announced, the company has recently expanded its US sales and clinical team in preparation for the national product launch of LockeT.

Accesswire | 11 months ago
Catheter Precision, Inc. Announces New Chief Financial Officer

Catheter Precision, Inc. Announces New Chief Financial Officer

FORT MILL, SC / ACCESSWIRE / January 7, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has brought on board Philip Anderson, to take on the position of Chief Financial Officer. Margrit Thomassen, who has been our Interim Chief Financial Officer, will continue with the company in the role of Controller.

Accesswire | 11 months ago

Catheter Precision, Inc. (VTAK) FAQ

What is the stock price today?

The current price is $2.52.

On which exchange is it traded?

Catheter Precision, Inc. is listed on AMEX.

What is its stock symbol?

The ticker symbol is VTAK.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 2.6M.

Has Catheter Precision, Inc. ever had a stock split?

Catheter Precision, Inc. had 4 splits and the recent split was on Aug 15, 2025.

Catheter Precision, Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
David A. Jenkins CEO
AMEX Exchange
US74933X7084 ISIN
US Country
22 Employees
- Last Dividend
15 Aug 2025 Last Split
27 Sep 2018 IPO Date

Overview

Catheter Precision, Inc., initially known as Ra Medical Systems, Inc., is a pioneer in the field of electrophysiology products, focusing on enhancing the quality of life for patients suffering from cardiac arrhythmias across the United States. With its main operations based in Fort Mill, South Carolina, Catheter Precision, Inc. is at the forefront of developing and supplying advanced technologies and solutions tailored for patients, hospitals, and physicians alike. The rebranding to Catheter Precision, Inc. in August 2023 signifies a focus on its core competencies in catheter-based medical technologies. Through its innovative approaches and dedication to healthcare advancements, the company is playing a crucial role in the management and treatment of cardiac arrhythmias.

Products and Services

  • View into Ventricular Onset System
  • This non-invasive imaging system represents a breakthrough in the diagnosis and treatment of idiopathic ventricular arrhythmias, particularly for patients with structurally normal hearts. The View into Ventricular Onset System utilizes 3D cardiac mapping technology, assisting physicians in precisely localizing the sites of origin of ventricular arrhythmias before undergoing Electrophysiology (EP) procedures. This advanced diagnostic tool fundamentally enhances the pre-procedure planning, offering a novel approach to cardiac care.

  • LockeT
  • LockeT is an innovative suture retention device designed to improve clinical outcomes for patients requiring catheter-based interventions. This device is engineered to secure catheters in place, effectively minimizing the risk of displacement and potential complications associated with catheter movement. The introduction of LockeT in the market underscores Catheter Precision, Inc.'s commitment to not only diagnostic solutions but also to procedural safety and efficiency.

  • Amigo Remote Catheter System
  • The Amigo Remote Catheter System incorporates robotic technology in the form of a robotic arm, which acts as a catheter control device. This system is crafted to provide physicians with unprecedented control and precision during catheter manipulation, enhancing the accuracy and safety of catheter-based cardiac procedures. By facilitating remote control of catheters, Amigo serves as a cornerstone in the evolution of minimally invasive cardiac interventions, reinforcing Catheter Precision, Inc.'s role in pioneering medical technology innovation.

Contact Information

Address: 1670 Highway 160 West
Phone: 973 691 2000